Home > Healthcare > Biotechnology > Bioservices > Downstream Processing Market
Downstream Processing Market Size
- Report ID: GMI6479
- Published Date: Aug 2023
- Report Format: PDF
Downstream Processing Market Size
Downstream Processing Market size was valued at USD 11.7 billion in 2023 and is anticipated to expand at a CAGR of 10.5% between 2024 and 2032, driven by factors such as growing demand for biopharmaceuticals, increasing R&D expenditure in biopharmaceutical industries, and rise in the prominence of contract manufacturing organizations (CMOs).
Downstream processing involves the purification, separation, and recovery of bio-based products, mainly pharmaceuticals such as proteins, antibodies, vaccines, enzymes, and other therapeutic molecules, after being produced by using biotechnological processes like fermentation or cell culture. The ultimate goal of downstream processing is to separate and purify the target molecule from the complex mixture of cell culture media, cell debris, contaminants, and other biomolecules. This is essential to make sure that the finished product meets required quality, safety, and efficacy standards for its intended use.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Downstream Processing Market Size in 2023: | USD 11.7 Billion |
| Forecast Period: | 2024 to 2032 |
| Forecast Period 2024 to 2032 CAGR: | 10.5% |
| 2032 Value Projection: | USD 28.8 Billion |
| Historical Data for: | 2018 to 2023 |
| No. of Pages: | 300 |
| Tables, Charts & Figures: | 516 |
| Segments covered: | Technique, Product, Application, End-user, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Downstream Processing Market Scope
